Effect of Fetal Ovarian Cyst Aspiration to Prevent Torsion

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Tours
ClinicalTrials.gov Identifier:
NCT00222066
First received: September 19, 2005
Last updated: February 2, 2010
Last verified: September 2006

September 19, 2005
February 2, 2010
June 2001
January 2007   (final data collection date for primary outcome measure)
To avoid neonatal surgery [ Time Frame: 3 months after birth ] [ Designated as safety issue: No ]
To avoid neonatal surgery
Complete list of historical versions of study NCT00222066 on ClinicalTrials.gov Archive Site
  • Ultrasound pattern of neonatal ovarian cyst [ Time Frame: 3 months after birth ] [ Designated as safety issue: No ]
  • Maternal and fetal/neonatal safety of prenatal ovarian cyst aspiration [ Time Frame: 3 months after birth ] [ Designated as safety issue: Yes ]
  • Ultrasound pattern of neonatal ovarian cyst
  • Maternal and fetal/neonatal safety of prenatal ovarian cyst aspiration
Not Provided
Not Provided
 
Effect of Fetal Ovarian Cyst Aspiration to Prevent Torsion
Comparison Between Abstention and Intrauterine Aspiration in the Treatment of Anechoic Fetal Ovarian Cysts to Prevent Ovarian Torsion

The purpose of this study is to determine whether prenatal ovarian cyst aspiration is effective and safe to prevent perinatal ovarian torsion.

With the widespread use of routine sonography during pregnancy, the incidence of fetal ovarian cysts detected in utero has increased in the past decades. However

Interventional
Not Provided
Allocation: Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
  • Ovarian Cyst
  • Ultrasonography Prenatal
Procedure: Fetal ovarian cyst aspiration
Fetal ovarian cyst aspiration performed under ultrasound guidance and maternal local anesthesia
  • Experimental: 1
    Fetal ovarian cyst aspiration performed as soon as possible
    Intervention: Procedure: Fetal ovarian cyst aspiration
  • No Intervention: 2
    Expectative

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
61
September 2007
January 2007   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • Pregnant women having an uneventful single pregnancy and a female fetus diagnosed with anechoic ovarian cyst (diameter at least 30mm)

Exclusion Criteria:

  • Multiple pregnancy
  • Complicated pregnancy (PE, diabetes, PROM, fetal malformation)
  • Echoic cyst (fluid debris level, septated, retracting clot, globally echoic)
  • Unability to give informed consent
Female
18 Years to 40 Years
No
Contact information is only displayed when the study is recruiting subjects
France
 
NCT00222066
OV-UTERO 2000
Yes
Pr Franck Perrotin, CHRU de Tours
University Hospital, Tours
Not Provided
Principal Investigator: Franck Perrotin, MD--PhD Tours University Hospital
University Hospital, Tours
September 2006

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP